Ambulero is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease. We are a platform company that can deliver the adhesion molecule E-selectin using different cell and synthetic vector technologies. We work on rare vascular diseases as well as more common indications effecting large patient populations.
Company Details
- Employees
- 3
- Founded
- 2019
- Address
- 1951 Nw 7th Ave,
- ca****@****ero.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- ambulero.com
- HQ
- Miami, Florida
Ambulero Questions
Ambulero's website is ambulero.com
Ambulero's LinkedIn profile is https://www.linkedin.com/company/ambulero
Ambulero has
3 employees.
View email and phone details for 3
employees at Ambulero.
Ambulero's industry is
Biotechnology Research
Ambulero's top competitors are
Ambulera Group,
Rora Biologics,
Orbit Genomics,
Fastback Bio Llc,
Jtm Construction,
Ventac Partners,
Eysz,
Chosan,
Pacific Coast Electrical Contractors, Inc.,
Chiying Trading Co., Ltd..
Ambulero's support email address is canderson@ambulero.com
Ambulero's categories are Biotechnology Research
Ambulero's founding year is 2019
